Department of Thoracic Surgery, A.O. San Paolo, University of Milan, Milan, Italy.
Department of Thoracic Surgery, A.O. San Paolo, University of Milan, Milan, Italy.
J Thorac Cardiovasc Surg. 2014 Jan;147(1):469-73. doi: 10.1016/j.jtcvs.2013.09.024. Epub 2013 Nov 1.
Pain control after thoracotomy prevents postsurgical complications and improves respiratory function. The gold standard for post-thoracotomy analgesia is the epidural catheter. The aim of this study was to compare it with a new technique that involves placement of a catheter in the paravertebral space at the end of surgery under a surgeon's direct vision.
From November 2011 to June 2012, 52 patients were randomized into 2 groups depending on catheter placement: an epidural catheter for group A and a paravertebral catheter for group B. At 12, 24, 48, and 72 hours after surgery, the following parameters were recorded: (1) pain control using the patient's completion of a visual analog scale module, (2) respiratory function using forced expiratory volume in 1 second and ambient air saturation, and (3) blood cortisol values as an index of systemic reaction to pain.
Statistically significant differences (P < .05) were found in favor of group B for both cough and rest pain control (P = .002 and .002, respectively) and respiratory function in terms of forced expiratory volume in 1 second and ambient air saturation levels (P = .023 and .001, respectively). No statistically significant differences were found in blood cortisol trends between the 2 groups (P > .05). Collateral effects such as vomiting, nausea, low pressure, or urinary retention were observed only in group A. No collateral effects were recorded in the paravertebral group.
According to our data, drugs administered through a paravertebral catheter are very effective. Moreover, it does not present contraindications to its positioning or collateral effects. More studies are necessary to confirm data we collected.
开胸术后疼痛控制可预防术后并发症并改善呼吸功能。硬膜外导管是开胸术后镇痛的金标准。本研究旨在比较一种新的技术,即在外科医生直视下将导管直接放置在手术结束时的椎旁间隙。
2011 年 11 月至 2012 年 6 月,根据导管放置情况将 52 例患者随机分为 2 组:硬膜外导管组(A 组)和椎旁导管组(B 组)。术后 12、24、48 和 72 小时记录以下参数:(1)采用患者完成视觉模拟评分量表评估疼痛控制情况;(2)采用 1 秒用力呼气量和环境空气饱和度评估呼吸功能;(3)采用血皮质醇值作为全身疼痛反应的指标。
在咳嗽和休息时疼痛控制(P =.002 和.002)以及用力呼气量和环境空气饱和度方面的呼吸功能(P =.023 和.001)方面,B 组均显示出明显优于 A 组的差异(P <.05)。两组间血皮质醇趋势无统计学差异(P >.05)。A 组仅观察到呕吐、恶心、低血压或尿潴留等并发症,B 组无并发症发生。
根据我们的数据,通过椎旁导管给予的药物非常有效。此外,它不存在定位或副作用的禁忌症。需要更多的研究来证实我们收集的数据。